Septerna, Inc. Operating Income
Septerna, Inc. (SEPN) reported Operating Income of -$16.84 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-10
- Septerna, Inc. operating income (loss) for the quarter ending 2026-06-30 was -$16.84M.
- Septerna, Inc. operating income (loss) for the quarter ending 2026-03-31 was -$13.30M.
- Septerna, Inc. operating income (loss) for the quarter ending 2025-12-31 was -$16.02M.
- Septerna, Inc. operating income (loss) for the quarter ending 2025-09-30 was $2.61M.
- Septerna, Inc. operating income (loss) for fiscal 2025 was -$68.30M.
- Septerna, Inc. operating income (loss) for fiscal 2024 was -$80.82M, a 3995.08% decline from fiscal 2023.
- Septerna, Inc. operating income (loss) for fiscal 2023 was $2.08M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$16.84M 10-Q · filed 2026-08-10 | -$30.14M 10-Q · filed 2026-08-10 | -$46.16M derived: sum of 3 quarters · filed 2026-08-10 | -$43.55M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | -$13.30M 10-Q · filed 2026-05-11 | -$29.32M derived: sum of 2 quarters · filed 2026-05-11 | -$26.71M derived: sum of 3 quarters · filed 2026-05-11 | -$55.69M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | -$16.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$13.41M derived: sum of 2 quarters · filed 2026-03-09 | -$42.39M derived: sum of 3 quarters · filed 2026-08-10 | -$68.30M 10-K · filed 2026-03-09 |
| 2025-09-30 | $2.61M 10-Q · filed 2025-11-10 | -$26.36M derived: sum of 2 quarters · filed 2026-08-10 | -$52.27M 10-Q · filed 2025-11-10 | -$76.99M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | -$28.98M 10-Q · filed 2026-08-10 | -$54.89M 10-Q · filed 2026-08-10 | -$79.61M derived: sum of 3 quarters · filed 2026-08-10 | -$102.16M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | -$25.91M 10-Q · filed 2026-05-11 | -$50.63M derived: sum of 2 quarters · filed 2026-05-11 | -$73.18M derived: sum of 3 quarters · filed 2026-05-11 | -$91.24M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | -$24.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$47.27M derived: sum of 2 quarters · filed 2026-03-09 | -$65.33M derived: sum of 3 quarters · filed 2026-03-09 | -$80.82M 10-K · filed 2026-03-09 |
| 2024-09-30 | -$22.55M 10-Q · filed 2025-11-10 | -$40.62M derived: sum of 2 quarters · filed 2025-11-10 | -$56.10M 10-Q · filed 2025-11-10 | -$21.79M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | -$18.07M 10-Q · filed 2025-08-11 | -$33.55M 10-Q · filed 2025-08-11 | $762.00K derived: sum of 3 quarters · filed 2025-08-11 | -$11.28M derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | -$15.49M 10-Q · filed 2025-05-15 | $18.83M derived: sum of 2 quarters · filed 2025-05-15 | $6.79M derived: sum of 3 quarters · filed 2025-05-15 | |
| 2023-12-31 | $34.32M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $22.28M derived: sum of 2 quarters · filed 2025-03-27 | $2.08M 10-K · filed 2025-03-27 | |
| 2023-09-30 | -$12.04M 10-Q · filed 2024-11-20 | -$32.24M 10-Q · filed 2024-11-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |